Syneos Health_rgb_r.jpg
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
April 19, 2022 08:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
Syneos Health_rgb_r.jpg
Syneos Health Schedules First Quarter 2022 Earnings Call for Friday, April 29th, 2022
April 11, 2022 16:05 ET | Syneos Health, Inc.
MORRISVILLE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health_rgb_r.jpg
Syneos Health Reports Fourth Quarter and Full Year 2021 Results
February 17, 2022 06:10 ET | Syneos Health, Inc.
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
Syneos Health_rgb_r.jpg
Syneos Health Schedules Fourth Quarter and Full Year 2021 Earnings Call for Thursday, February 17th, 2022
February 01, 2022 07:26 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health_rgb_r.jpg
Syneos Health Appoints Two New Independent Directors
January 18, 2022 06:16 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health_rgb_r.jpg
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
January 11, 2022 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
Syneos Health_rgb_r.jpg
Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 09:06 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health_rgb_r.jpg
Syneos Health Releases 2022 Health Trends
December 21, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for...
Syneos Health_rgb_r.jpg
Syneos Health to Present at Upcoming Investor Conferences
November 11, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...
Syneos Health_rgb_r.jpg
Syneos Health Reports Third Quarter 2021 Results
November 03, 2021 06:16 ET | Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...